NasdaqGS - Nasdaq Real Time Price • USD
ICON Public Limited Company (ICLR)
As of 2:30 PM EDT. Market Open.
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 14 | 14 | 16 | 16 |
Avg. Estimate | 3.64 | 3.85 | 14.96 | 17.12 |
Low Estimate | 3.49 | 3.73 | 14.74 | 15.55 |
High Estimate | 3.77 | 3.91 | 15.07 | 17.55 |
Year Ago EPS | 3.11 | 3.3 | 12.79 | 14.96 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 14 | 14 | 16 | 16 |
Avg. Estimate | 2.14B | 2.19B | 8.64B | 9.28B |
Low Estimate | 2.11B | 2.15B | 8.51B | 9.02B |
High Estimate | 2.19B | 2.21B | 8.75B | 9.45B |
Year Ago Sales | -- | 2.05B | 8.12B | 8.64B |
Sales Growth (year/est) | -- | 6.60% | 6.40% | 7.40% |
Earnings History
CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
---|---|---|---|---|
EPS Est. | 3.08 | 3.28 | 3.44 | 3.41 |
EPS Actual | 3.11 | 3.3 | 3.46 | 3.47 |
Difference | 0.03 | 0.02 | 0.02 | 0.06 |
Surprise % | 1.00% | 0.60% | 0.60% | 1.80% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 3.64 | 3.85 | 14.96 | 17.12 |
7 Days Ago | 3.61 | 3.85 | 14.94 | 17.07 |
30 Days Ago | 3.61 | 3.87 | 14.94 | 17.05 |
60 Days Ago | 3.61 | 3.87 | 14.95 | 17.15 |
90 Days Ago | 3.64 | 3.82 | 14.92 | 17.09 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | 8 | 5 | 7 | 8 |
Up Last 30 Days | 8 | 6 | 8 | 8 |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | 2 | 4 | 2 | 3 |
Growth Estimates
CURRENCY IN USD | ICLR | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | 17.00% | -- | -- | 1.50% |
Next Qtr. | 16.70% | -- | -- | 12.10% |
Current Year | 17.00% | -- | -- | 4.40% |
Next Year | 14.40% | -- | -- | 13.20% |
Next 5 Years (per annum) | 14.87% | -- | -- | 10.97% |
Past 5 Years (per annum) | 19.95% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Maintains | TD Cowen: Buy to Buy | 4/26/2024 |
Maintains | Evercore ISI Group: Outperform to Outperform | 4/26/2024 |
Maintains | Baird: Outperform to Outperform | 4/26/2024 |
Maintains | Baird: Outperform to Outperform | 4/4/2024 |
Reiterates | Mizuho: Buy to Buy | 4/4/2024 |
Maintains | Evercore ISI Group: Outperform to Outperform | 2/23/2024 |
Related Tickers
IQV IQVIA Holdings Inc.
235.72
+0.74%
MEDP Medpace Holdings, Inc.
394.77
+1.28%
CRL Charles River Laboratories International, Inc.
229.44
+0.72%
LH Laboratory Corporation of America Holdings
198.36
+0.01%
DGX Quest Diagnostics Incorporated
134.95
-0.35%
IDXX IDEXX Laboratories, Inc.
498.08
+1.81%
MTD Mettler-Toledo International Inc.
1,241.00
+0.66%
WAT Waters Corporation
310.60
+0.73%
RDNT RadNet, Inc.
48.69
-0.33%
NTRA Natera, Inc.
91.72
+0.48%